Israel-Based Clearmind Successfully Completed Two R&D Projects With The Hebrew University of Jerusalem's Tech Transfer Company Yissum

Clearmind Medicine Inc. , , a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the... | January 21, 2023

Related Keywords

Boston ,Massachusetts ,United States ,Jerusalem ,Israel General ,Israel ,Canada ,Hebrew University ,Yerushalayim ,Frankfurt ,Brandenburg ,Germany ,Canadian ,Ahmad Masarwa ,Dmitry Tsvelikhovsky ,Adi Zuloff Shani ,Avi Priel ,Clearmind Medicine Inc ,Boston Scientific ,Frankfurt Stock Exchange ,Nasdaq ,Novartis ,Exchange Commission ,Hebrew University Of Jerusalem ,Canadian Securities Exchange ,Johnson ,Intel ,Clearmind Medicine ,Professor Dmitry Tsvelikhovsky ,Stock Exchange ,Private Securities Litigation Reform Act ,News Publishing ,Clearmind Medicine Inc Stock Exchange ,News ,Information ,Press Release ,Clearmind ,Medicine ,Biotech ,Company ,Ocused ,N ,Discovery ,End ,Development ,F ,Novel ,Herapeutics ,O ,Solve ,Major ,Health ,Oday ,Nnounced Cmnd Ca1850532047 ,